| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.21B | +20.1% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.04B | +61.2% |
| Gross margin | 32.8% | Net margin 21.4% |
| Revenue Q/Q | -27.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.14B | 67.2% |
| R&D | ¥0.01B | 4.7% |
| SG&A | ¥0.02B | 8.9% |
| Tax & other | ¥0.00B | 2.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
国投智能 ・ 神农种业 ・ 维尔利 ・ 潜能恒信 ・ 科德教育 ・ 佳士科技 ・ 福安药业 ・ 长荣股份 ・ 长海股份 ・ 节能铁汉 ・ *ST纳川 ・ 翰宇药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies